Order Article Reprints

Demirsoy S, Tran H, Liu J, Li Y, Yang S, Aregawi D, Glantz MJ, Jacob NK, Walter V, Schell TD, et al. Targeting Tyro3, Axl, and MerTK Receptor Tyrosine Kinases Significantly Sensitizes Triple-Negative Breast Cancer to CDK4/6 Inhibition. Cancers. 2024; 16(12):2253. https://doi.org/10.3390/cancers16122253

Demirsoy, Seyma, Ha Tran, Joseph Liu, Yunzhan Li, Shengyu Yang, Dawit Aregawi, Michael J. Glantz, Naduparambil K. Jacob, Vonn Walter, Todd D. Schell, and et al. 2024. "Targeting Tyro3, Axl, and MerTK Receptor Tyrosine Kinases Significantly Sensitizes Triple-Negative Breast Cancer to CDK4/6 Inhibition" Cancers 16, no. 12: 2253. https://doi.org/10.3390/cancers16122253

Demirsoy, S., Tran, H., Liu, J., Li, Y., Yang, S., Aregawi, D., Glantz, M. J., Jacob, N. K., Walter, V., Schell, T. D., & Olmez, I. (2024). Targeting Tyro3, Axl, and MerTK Receptor Tyrosine Kinases Significantly Sensitizes Triple-Negative Breast Cancer to CDK4/6 Inhibition. Cancers, 16(12), 2253. https://doi.org/10.3390/cancers16122253